A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma

Figure 4

Evaluation of the clinical application value of the risk signature in the training cohort. (a) Univariate and multivariate Cox regression analyses of risk score and clinicopathological characteristics. (b) The nomogram constructed by risk scores and clinicopathological characteristics predicts the 1-, 3-, and 5-year survival rates of patients in the training cohort. (c) The calibration curves describe the consistency between the nomogram predicted 1-, 3-, and 5-year survival and actual survival. The red solid line represents the predicted performance of the nomogram, and the 45° dashed line represents an ideal prediction model. A higher overlap between the red solid line and the dashed line indicates better nomogram prediction performance.

(a)

(b)

(c)